Mucovan 100ml Syrup

Ambroxol 15 mg / 5 ml

COMPOSITION

Mucovan Syrup: Each 5 ml of syrup contains Ambroxol Hydrochloride BP 15 mg.

PHARMACOLOGY

Mucovan (Ambroxol) is the active metabolite of bromhexine and it has been proven that this metabolite possesses a greater bronchosecretolytic effect than bromhexine. It improves sputum rheology by hydrating mechanism leading to liquefaction of mucus in the lumen of respiratory tract, thus facilitating expectoration of mucus and reducing dyspnea. It stimulates production of phospholipids of surfactant by alveolar cells, thus contributing to the lowering of superficial tension in the alveoli. It also reduces bronchial hyperactivity. Mucovan (Ambroxol) has anti-inflammatory properties owing to the inhibitory effect on the production of cellular cytokines and arachidonic acid metabolites. In patients with COPD it traditionally improves airway patency

INDICATION

Mucovan (Ambroxol) is used in the treatment of Productive cough, Acute and chronic inflammatory disorders of upper and lower respiratory tracts associated with viscid mucus including acute and chronic bronchitis, Inflammatory disease of rhinopharyngeal tract (laryngitis, pharyngitis, sinusitis and rhinitis) associated with viscid mucus, Asthmatic bronchitis, bronchial asthma with thick expectoration, Bronchiectasis & Chronic pneumonia etc.

DOSE AND ADMINISTRATION

Average daily dose (preferably after meal)

2-5 years: 2.5 ml (1/2 teaspoonful) 2-3 times a day

5-10 years: 5 ml (1 teaspoonful) 2-3 times a day

10 years and adults: 10 ml (2 teaspoonful) 3 times a day.

CONTRAINDICATION

Contraindicated in known hypersensitivity to Ambroxol or Bromhexine.

WARNING AND PRECAUTION

Mucovan (Ambroxol) should be given cautiously to patients with gastric and duodenal ulceration or convulsive disorders. Patients with hepatic and renal insufficiency should take it with caution

SIDE EFFECTS

Gastrointestinal side effects like epigastric pain, stomach overfill feeling may occur occasionally. Rarely allergic responses such as eruption, urticaria or angioneurotic edema has been reported.

USE IN PREGNANCY AND LACTATION

Teratogenic and foetal toxicity studies have shown no harmful effect of Ambroxol. However, it is advised not to use it in pregnancy, especially during theist trimester. Safety during lactation has not been established yet.

DRUG INTERACTION

Mucovan (Ambroxol) should not be taken simultaneously with antitussives (e.g. Codeine) because phlegm, which has been liquefied by Ambroxol might not be expectorated.

STORAGE 

Store in a cool & dry place below 30º C. Protect from light and moisture. Keep out of reach of children.

PACKING

Mucovan Syrup: Bottle contains 100 ml syrup and a measuring cup.

Mucovan 100ml Syrup
Scroll to top